Ngā hua rapu - James Doherty

Whakamahine hua
  1. 1
    Reduced Excitatory Drive onto Interneurons in the Dentate Gyrus after Status Epilepticus

    Reduced Excitatory Drive onto Interneurons in the Dentate Gyrus after Status Epilepticus mā James Doherty, Raymond Dingledine

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Altered Histone Acetylation at<i>Glutamate Receptor 2</i>and<i>Brain-Derived Neurotrophic Factor</i>Genes Is an Early Event Triggered by Status Epilepticus

    Altered Histone Acetylation at<i>Glutamate Receptor 2</i>and<i>Brain-Derived Neurotrophic Factor</i>Genes Is an Early Event Triggered by Status Epilepticus mā Yunfei Huang, James Doherty, Raymond Dingledine

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Stimulus-Specific Adaptation in Auditory Cortex Is an NMDA-Independent Process Distinct from the Sensory Novelty Encoded by the Mismatch Negativity

    Stimulus-Specific Adaptation in Auditory Cortex Is an NMDA-Independent Process Distinct from the Sensory Novelty Encoded by the Mismatch Negativity mā Brandon J. Farley, Michael C. Quirk, James Doherty, Edward P. Christian

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Rapid force generation during unilateral isometric hamstring assessment: reliability and relationship to maximal force

    Rapid force generation during unilateral isometric hamstring assessment: reliability and relationship to maximal force mā Nicholas J. Ripley, James Doherty, Matthew Cuthbert, John J. McMahon, Paul Comfort

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism

    Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism mā Amit Modgil, Manasa L. Parakala, Michael A. Ackley, James Doherty, Stephen J. Moss, Paul Davies

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression

    Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression mā Stephen Kanes, Helen Colquhoun, James Doherty, Shane Raines, Ethan Hoffmann, David R. Rubinow, Samantha Meltzer‐Brody

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    An Outcome-based Approach for the Creation of Fetal Growth Standards: Do Singletons and Twins Need Separate Standards?

    An Outcome-based Approach for the Creation of Fetal Growth Standards: Do Singletons and Twins Need Separate Standards? mā K.S. Joseph, James Doherty, Robert W. Platt, Robert M. Liston, S. K. Lee, Reg Sauvé, S. Liu, A C Allen, M. S. Kramer

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Brexanolone as adjunctive therapy in super‐refractory status epilepticus

    Brexanolone as adjunctive therapy in super‐refractory status epilepticus mā Eric S. Rosenthal, Jan Claassen, Mark S. Wainwright, Aatif M. Husain, Henrikas Vaitkevicius, Shane Raines, Ethan Hoffmann, Helen Colquhoun, James Doherty, Stephen Kanes

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease

    Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐fin... mā Aaron Koenig, Michael Lewis, Jeff Wald, Sigui Li, Mustafa Varoglu, Jing Dai, Abdul J. Sankoh, Katrina Paumier, James Doherty, Mike Quirk

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABAA receptors

    Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABAA receptors mā Manasa L. Parakala, Yihui Zhang, Amit Modgil, Jayashree Chadchankar, Thuy N. Vien, Michael A. Ackley, James Doherty, Paul Davies, Stephen J. Moss

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies

    SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies mā Ethan Hoffmann, George G. Nomikos, Inder Kaul, Shane Raines, Jeff Wald, Amy Bullock, Abdul J. Sankoh, James Doherty, Stephen Kanes, Helen Colquhoun

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Different oxysterols have opposing actions at N-methyl-d-aspartate receptors

    Different oxysterols have opposing actions at N-methyl-d-aspartate receptors mā Andrew J. Linsenbardt, Amanda Taylor, Christine M. Emnett, James Doherty, Kathiresan Krishnan, Douglas F. Covey, Steven M. Paul, Charles F. Zorumski, Steven Mennerick

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Chemotherapeutic response to cisplatin-like drugs in human breast cancer cells probed by vibrational microspectroscopy

    Chemotherapeutic response to cisplatin-like drugs in human breast cancer cells probed by vibrational microspectroscopy mā Ana L. M. Batista de Carvalho, Michael J. Pilling, Peter Gardner, James Doherty, Gianfelice Cinque, Katia Wehbe, Chris S. Kelley, Luís A. E. Batista de Carvalho, M. Paula M. Marques

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis

    Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis mā Natasha Warikoo, Samuel J. Brunwasser, Ann Benz, Hong‐Jin Shu, Steven M. Paul, Michael Lewis, James Doherty, Michael C. Quirk, Laura Piccio, Charles F. Zorumski, Gregory S. Day, Steven Mennerick

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Effect of Zuranolone vs Placebo in Postpartum Depression

    Effect of Zuranolone vs Placebo in Postpartum Depression mā Kristina M. Deligiannidis, Samantha Meltzer‐Brody, Handan Gunduz‐Bruce, James Doherty, Jeffrey M. Jonas, Sigui Li, Abdul J. Sankoh, Christopher Silber, Andrew Campbell, Brian Werneburg, Stephen Kanes, Robert Lasser

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of<i>N</i>-Methyl-d-Aspartate Receptors

    The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of<i>N</i>-Methyl-d-Aspartate Receptors mā Steven M. Paul, James Doherty, Albert J. Robichaud, Gabriel M. Belfort, Brian Y. Chow, Rebecca Hammond, Devon C. Crawford, Andrew J. Linsenbardt, Hong‐Jin Shu, Yukitoshi Izumi, Steven Mennerick, Charles F. Zorumski

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis

    Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis mā Francesco Mannara, Marija Radosevic, Jesús Planagumà, David Soto, Esther Aguilar, Anna García‐Serra, Estibaliz Maudes, Marta Pedreño, Steven M. Paul, James Doherty, Michael C. Quirk, Jing Dai, Xavier Gasull, Michael Lewis, Josep Dalmau

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    <scp>AZD</scp>1080, a novel <scp>GSK</scp>3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans

    <scp>AZD</scp>1080, a novel <scp>GSK</scp>3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans mā Biljana Georgievska, Johan Sandin, James Doherty, Anette Mörtberg, Jan Neelissen, Anita Andersson, Susanne Gruber, Yvonne Nilsson, P.A. Schött, Per I. Arvidsson, Sven Hellberg, Gunilla Osswald, Stefan von Berg, Johanna Fälting, Ratan V. Bhat

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study

    Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study mā Sagar V. Parikh, Scott T. Aaronson, Sanjay J. Mathew, Gustavo Alva, Charles DeBattista, Stephen Kanes, Robert Lasser, Amy Bullock, Mona Kotecha, JungAh Jung, Fiona Forrestal, J. Jonas, Theresa Vera, Bridgette Leclair, James Doherty

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Trial of SAGE-217 in Patients with Major Depressive Disorder

    Trial of SAGE-217 in Patients with Major Depressive Disorder mā Handan Gunduz-Bruce, Christopher Silber, Inder Kaul, Anthony J. Rothschild, Robert Riesenberg, Abdul J. Sankoh, Haihong Li, Robert Lasser, Charles F. Zorumski, David R. Rubinow, Steven M. Paul, Jeffrey M. Jonas, James Doherty, Stephen Kanes

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: